Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
3.890
+0.090 (2.37%)
At close: Aug 28, 2025, 4:00 PM
3.850
-0.040 (-1.03%)
After-hours: Aug 28, 2025, 7:01 PM EDT

Ekso Bionics Holdings Stock Forecast

EKSO's stock price has decreased by -77.29% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Ekso Bionics Holdings stock have a consensus rating of "Strong Buy" and an average price target of $34.75, which forecasts a 793.32% increase in the stock price over the next year. The lowest target is $9.50 and the highest is $60.

Price Target: $34.75 (+793.32%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$9.50$34.75$60$60
Change+144.22%+793.32%+1442.4%+1442.4%
* Price targets were last updated on Jul 29, 2025.

Analyst Ratings

The average analyst rating for Ekso Bionics Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Strong Buy
Maintains
$15$9.5
Strong BuyMaintains$15$9.5+144.22%Jul 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$135$60
Strong BuyMaintains$135$60+1,442.42%May 6, 2025
Lake Street
Lake Street
Strong Buy
Maintains
$30$15
Strong BuyMaintains$30$15+285.60%Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$135
Strong BuyReiterates$135+3,370.44%Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$135
Strong BuyReiterates$135+3,370.44%Jan 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
16.94M
from 17.93M
Decreased by -5.49%
Revenue Next Year
25.40M
from 16.94M
Increased by 49.96%
EPS This Year
-5.51
from -8.43
EPS Next Year
-2.38
from -5.51
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.88M11.25M12.91M18.28M17.93M16.94M25.40M
Revenue Growth
-36.18%26.62%14.81%41.57%-1.94%-5.49%49.96%
EPS
-33.15-13.20-17.45-16.50-8.43-5.51-2.38
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High19.1M27.9M
Avg16.9M25.4M
Low14.7M22.7M

Revenue Growth

Revenue Growth202520262027
High
6.7%
64.9%
Avg
-5.5%
50.0%
Low
-18.0%
34.3%

EPS Forecast

EPS202520262027
High-5.35-1.43
Avg-5.51-2.38
Low-5.59-3.23

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.